The Purification and Immunogenicity of TB-14 Recombinant Protein of Mycobacterium tuberculosis

결핵균 특이 TB-14 재조합 단백질의 분리 및 세포성 면역반응에 미치는 영향

  • Song, Ho-Yeon (Department of Microbiology, College of Medicine, Soonchunhyang University) ;
  • Kim, Young-Hee (Department of Microbiology, College of Medicine, Soonchunhyang University) ;
  • Kim, Chang-Hwan (Department of Microbiology, College of Medicine, Soonchunhyang University) ;
  • Min, Young-Ki (Department of Physiology, College of Medicine, Soonchunhyang University) ;
  • Kim, Dae-Joong (Department of Pathology, Cheongju St. Mary Hospital) ;
  • Ko, Kwang-Kjune (Department of Microbiology, College of Medicine, Soonchunhyang University)
  • 송호연 (순천향대학교 의과대학 미생물학교실) ;
  • 김영희 (순천향대학교 의과대학 미생물학교실) ;
  • 김창환 (순천향대학교 의과대학 미생물학교실) ;
  • 민영기 (순천향대학교 의과대학 생리학교실) ;
  • 김대중 (청주성모병원 병리과) ;
  • 고광균 (순천향대학교 의과대학 미생물학교실)
  • Received : 2006.07.19
  • Accepted : 2006.08.28
  • Published : 2006.09.30

Abstract

Background: Culture filtrate proteins secreted by mycobacteria are thought to play an important role in inducing protective immunity and to develop new methods for diagnosing tuberculosis. Methods: A culture filtrate protein of M. avium that was strongly reactive with goat antiserum against M. intracellulare was constructed. Its homologous protein (TB-14) in M. tuberculosis was cloned, expressed and purified. The inductions of IFN-${\gamma}$ stimulated with $10{\mu}g$ of TB-14 recombinant protein and $10{\mu}g$ PPD were estimated by using whole bloods from seven PPD (-) subjects, seven PPD (+) healthy volunteers and nine tuberculosis patients. Results: M. avium culture filtrate protein was confirmed as a hypothetical protein that was termed contig 116. A novel 14-kDa recombinant protein (TB-14) of M. tuberculosis was composed of 148 amino acids, including 30 amino acids of the signal peptide, and it showed 78% homology with M. avium. In the PPD (+) healthy volunteers, recombinant TB-14 protein strongly induced the secretion of IFN-${\gamma}$ in whole blood cultures. Conclusion: These results suggest that TB-14 recombinant protein might play an important role in inducing cell-mediated immunity against tuberculosis. Furthermore, TB-14 protein antigen and its antiserum will be available for the development of new diagnostic tools for tuberculosis.

연구배경: Mycobacteria 배양액 여과 단백질은 결핵에 대한 세포성 면역반응 및 진단 연구에 중요한 역할을 하는 것으로 알려져 있다. 새로운 결핵균 특이 유전자를 클로닝하여 약 14-kDa의 결핵균 재조합 단백질(TB-14)을 분리 정제 한 뒤 전혈 배양(whole blood culture)을 통해 재조합 단백질 항원의 자극에 따른 IFN-${\gamma}$ 분비 유도를 PPD와 비교 측정하여 TB-14 단백질이 결핵균에 대한 숙주의 세포성 면역반응 유도에 어떤 역할을 하는 지를 알아보고자 하였다. 방 법: M. avium 배양 여과액에서 항혈청과 강하게 반응하는 하나의 M. avium 특이 단백질을 확인하여 아미노산 서열을 규명한 뒤 이 단백질과 높은 상동성을 나타내는 M. tuberculosis 유전자를 클로닝하여 다량의 결핵균 재조합 단백질(TB-14)을 분리 정제하였다. 재조합 단백질 TB-14에 대한 세포성 면역 반응 유도를 알아보기 위해 결핵 환자(9명), PPD 양성 정상인(7명) 및 PPD 음성 정상인(7명)들로부터 얻은 전혈(whole blood)를 RPMI로 희석한 뒤 $10{\mu}g$의 PPD와 TB-14 단백질로 48 시간 동안 자극하여 상층액에 분비된 IFN-${\gamma}$ 농도를 ELISA로 측정하였다. 결 과: 1. M. avium LR114F 균주의 배양 여과액 내에서 M. intracellulare 항혈청에 강하게 반응하는 새로운 M. avium 특이 단백질을 규명하여 아미노산 서열을 확인하였다. 2. M. avium 특이 단백질과 상동성을 보이는 M. tuberculosis 특이 재조합 단백질인 TB-14은 148개의 아미노산으로 구성되어 있고 30개의 아미노산으로 이루어진 signal peptides를 가지며 M. avium과 78%의 상동성을 보였다. 3. PPD 양성인의 전혈 배양에서 TB-14 단백질 항원으로 자극된 군에서 PPD로 자극된 군보다 월등히 높은 IFN-${\gamma}$ 분비를 나타내었다. 반면 결핵환자에서는 질환의 양상이나 치료 정도에 따라 IFN-${\gamma}$의 분비 양상이 일정하지 않았다. 결 론: 새로운 결핵균 특이 재조합 단백질 TB-14는 결핵에 대한 인체 내 세포성 면역반응 유도에 중요한 역할을 할 수 있는 단백질이라 생각되며 특히 PPD 양성자에서 높은 IFN-${\gamma}$의 분비 양상을 보여 정상인과 결핵 감염자의 감별진단에도 활용될 수 있으리라 생각된다. 또한 TB-14 단백질에 대한 항혈청을 제작하여 환자의 가검물에 분비되는 결핵균 특이 단백질을 탐색하는 결핵의 진단 연구에도 활용될 수 있을 것으로 사료된다.

Keywords

References

  1. World Health Organization. Global tuberculosis programme: the TB treatment observer. WHO Newsletter 1997
  2. World Health Organization. WHO declares tuberculosis a global emergency. Soz Praventivmed 1993:38:251-2 https://doi.org/10.1007/BF01624546
  3. World Health Organization. WHO report on the tuberculosis epidemic. Avail from: http://www.who.ch/
  4. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995;63: 1491-7
  5. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167: 1481-97 https://doi.org/10.1093/infdis/167.6.1481
  6. Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995:85: 502-8
  7. Young DB, Kaufmann SH, Hermans PW, Thole JE. Mycobacterial protein antigens: a compilation. Mol Microbiol 1992:6:133-45 https://doi.org/10.1111/j.1365-2958.1992.tb01994.x
  8. Ison CA, Anwer N, Cole MJ, Galassini R, Heyderman RS, Klein NJ, et al. Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog 1999:27:207-14 https://doi.org/10.1006/mpat.1999.0296
  9. Miles AA, Misra SS. The estimation of the bactericidal power of the blood. J Hyg 1938;38:732-49 https://doi.org/10.1017/S002217240001158X
  10. Wallis RS, Lederman HM, Spritzler J, Devers JL, Georges D, Weinberg A, et al. Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. Clin Diagn Lab Immunol 1998:5:556-60
  11. Wallis RS, Palaci M, Vinhas S, Hise AG, Ribeiro FC, landen K, et al. A whole blood bactericidal assay for tuberculosis. J Infect Dis 2001:183:1300-3 https://doi.org/10.1086/319679
  12. Bose M, Chander A, Das RH. A rapid and gentle method for the isolation of genomic DNA from mycobacteria. Nucleic Acids Res 1993:21:2529-30 https://doi.org/10.1093/nar/21.10.2529
  13. Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, magnusson M. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system. Scand J Immunol 1980:12:249-63 https://doi.org/10.1111/j.1365-3083.1980.tb00065.x
  14. Janicki BW, Chaparas SD, Daniel TM, Kubica GP, Wrigth GL, Yee GS. A reference system for antigens of Mycobacterium tuberculosis. Am Rev Respir Dis 1971:104:602-4
  15. Young DB, Kaufmann SH, Hermans PW, Thole JE. Mycobacterial protein antigens: a compilation. Mol Microbiol 1992:6:133-45 https://doi.org/10.1111/j.1365-2958.1992.tb01994.x
  16. Azuma I, Yamamura Y, Fukushi K. Fractionation of mycobacterial cell wall: isolation of arabinose mycolate and arabinogalactan from cell wall fraction of Mycobacterium tuberculosis strain Aoyama B. J Bacteriol 1968;96:1885-7
  17. Chaparas SD, Thor DE, Hedrick SR. Comparison of lymphocyte transformation, inhibition of macrophage migration and skin tests using dialyzable and nondialyzable tuberculin fractions from Mycobacterium bovis (BCG). J Immunol 1971:107:149-53
  18. Yamamura Y, Onoue K, Azuma I. Biology of the mycobacterioses: chemical and immunological studies on peptides and polysaccharides from tubercle bacilli. Ann N Y Acad Sci 1968:154:88-97 https://doi.org/10.1111/j.1749-6632.1968.tb16698.x
  19. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995:63:1710-7
  20. Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test: variavility with the Mantoux procedure. Am Rev Respir Dis 1985:132: 175-7
  21. Sippola AA, Gillespie SL, Lewis JA, Daniel TM. Mycobacterium avium antigenuria in patients with AIDS and disseminated M. avium disease. J Infect Dis 1993:168:466-8 https://doi.org/10.1093/infdis/168.2.466
  22. Choudhry V, Saxena RK. Detection of Mycobacterium tuberculosis antigens in urinary proteins of tuberculosis patients. Eur J Clin Microbiol Infect Dis 2002:21:1-5 https://doi.org/10.1007/s10096-001-0651-7
  23. Mazurek GH, Villarino ME. Guidelines for using the OuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis. MMWR Recomm Rep 2003:52:15-8
  24. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection an interferon-gamma based assay using new antigens. Am J Respir Crit Care Med 2004:170:59-64 https://doi.org/10.1164/rccm.200402-179OC